Osteoporosis

Osteoporosis
Osteoporosis is a disease of bones that leads to an increased risk of fracture. In osteoporosis the bone mineral density is reduced, bone microarchitecture deteriorates, and the amount and variety of proteins in bone is altered. Osteoporosis risks can be reduced with lifestyle changes and sometimes medication; in people with osteoporosis, treatment may involve both.
  • Vitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.
  • Since 2002, the U.S. Preventive Services Task Force has recommended that women ages 65 and older be routinely screened for osteoporosis and has suggested that a 2-year screening interval might be appropriate.
  • Taking drugs to prevent bone breakage may actually increase the chances for an unusual type of thigh bone fracture, Food and Drug Administration officials warned Wednesday.
  • The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk.
  • At a press conference held in Brussels today, the International Osteoporosis Foundation (IOF), the Belgian Bone Club and the European Parliament Osteoporosis Interest Group called on health care professionals and health policy officials in Europe to take action to prevent spinal fractures.
  • Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States.
  • Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture.
  • A novel nano-tomography method developed by a team of researchers from the Technische Universitaet Muenchen, the Paul Scherrer Institute and the ETH-Zurich opens the door to computed tomography examinations of minute structures at nanometer resolutions. Three-dimensional detailed imaging of fragile bone structures becomes possible. Their first nano-CT images will be published in Nature on Sept. 23, 2010. This new technique will facilitate advances in both life sciences and materials sciences.
  • Spanish researchers have confirmed there is a genetic risk factor for osteoporosis and bone fractures. Although more studies are still needed, these findings will make it possible to take preventive measures.
  • A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announced today that these same drugs – when used long term – may be related to unusual but serious fractures of the thigh bone. In the most comprehensive scientific report to date on the topic, the task force reviewed 310 cases of "atypical femur fractures," and found that 94 percent (291) of patients had taken the drugs, most for more than five years. The task force members emphasized that atypical femur fractures represent less than one percent of hip and thigh fractures overall and therefore are very uncommon.
  • University of Sydney researchers studying the impact of fractures from osteoporosis have found female sufferers experienced a significant reduction in their quality of life similar to or worse than that of patients with diabetes, arthritis, lung disease and other chronic illnesses.
  • Osteopenia is early sign of bone loss that can turn into osteoporosis. It is a precursor to the debilitating disease that results in disfigurement and serious bone problems.
More